Literature DB >> 15020256

Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: possible mediators of angiogenesis and matrix remodeling in the bone.

J Tombran-Tink1, C J Barnstable.   

Abstract

Pigment epithelial derived factor (PEDF) is one of the most effective inhibitors of angiogenesis described so far, especially in controlling the growth of blood vessels in the eye. We now describe the localization of PEDF in regions of active bone formation in the mid-gestation mouse embryo and its specific and high levels of secretion by osteoblasts. PEDF is detected to a lesser extent in osteoclasts as well. The proangiogenic factors, VEGF and its receptors VEGF-R1 and VEGF-R2, are also expressed by both osteoblasts and osteoclasts. These findings suggest that bone angiogenesis and matrix remodeling may be mediated both by PEDF and by VEGF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020256     DOI: 10.1016/j.bbrc.2004.02.076

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  47 in total

1.  Osteoclast-derived matrix metalloproteinase-9 directly affects angiogenesis in the prostate tumor-bone microenvironment.

Authors:  Alexandre Bruni-Cardoso; Lindsay C Johnson; Robert L Vessella; Todd E Peterson; Conor C Lynch
Journal:  Mol Cancer Res       Date:  2010-03-23       Impact factor: 5.852

2.  Identification of a Hoxc8-regulated transcriptional network in mouse embryo fibroblast cells.

Authors:  Haiyan Lei; Aster H Juan; Moo-Sang Kim; Frank H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-22       Impact factor: 11.205

3.  VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism.

Authors:  Qian Zhang; Ruolin Guo; Yan Lu; Lan Zhao; Quan Zhou; Edward M Schwarz; Jing Huang; Di Chen; Zheng-Gen Jin; Brendan F Boyce; Lianping Xing
Journal:  J Biol Chem       Date:  2008-03-20       Impact factor: 5.157

4.  MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts.

Authors:  Sonia Vallet; Noopur Raje; Kenji Ishitsuka; Teru Hideshima; Klaus Podar; Shweta Chhetri; Samantha Pozzi; Iris Breitkreutz; Tanyel Kiziltepe; Hiroshi Yasui; Enrique M Ocio; Norihiko Shiraishi; Janice Jin; Yutaka Okawa; Hiroshi Ikeda; Siddhartha Mukherjee; Nileshwari Vaghela; Diana Cirstea; Marco Ladetto; Mario Boccadoro; Kenneth C Anderson
Journal:  Blood       Date:  2007-08-22       Impact factor: 22.113

5.  Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue.

Authors:  Luis Cardoso; Brad C Herman; Olivier Verborgt; Damien Laudier; Robert J Majeska; Mitchell B Schaffler
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

6.  Localization of osteoblast inflammatory cytokines MCP-1 and VEGF to the matrix of the trabecula of the femur, a target area for metastatic breast cancer cell colonization.

Authors:  Karen M Bussard; Noriaki Okita; Neil Sharkey; Thomas Neuberger; Andrew Webb; Andrea M Mastro
Journal:  Clin Exp Metastasis       Date:  2010-05-06       Impact factor: 5.150

7.  Fluid flow-induced soluble vascular endothelial growth factor isoforms regulate actin adaptation in osteoblasts.

Authors:  Mia M Thi; Sylvia O Suadicani; David C Spray
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

8.  Pigment epithelium derived factor regulates human Sost/Sclerostin and other osteocyte gene expression via the receptor and induction of Erk/GSK-3beta/beta-catenin signaling.

Authors:  Feng Li; Jarret D Cain; Joyce Tombran-Tink; Christopher Niyibizi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-08-01       Impact factor: 5.187

9.  Effects of MgO, ZnO, SrO, and SiO2 in tricalcium phosphate scaffolds on in vitro gene expression and in vivo osteogenesis.

Authors:  Dongxu Ke; Solaiman Tarafder; Sahar Vahabzadeh; Susmita Bose
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2018-10-23       Impact factor: 7.328

Review 10.  New genes in bone development: what's new in osteogenesis imperfecta.

Authors:  Joan C Marini; Angela R Blissett
Journal:  J Clin Endocrinol Metab       Date:  2013-06-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.